OverT Bio is a clinical-stage biotechnology company developing next-generation, programmed off-the-shelf (allogeneic) cell therapies and biologics for solid tumors. The company pairs AI-powered genome-scale genetic discovery with tumor-targeting receptor engineering and naturally tumor-homing gamma delta T cells, plus scalable manufacturing… - View it on GitHub